Refine
Year of publication
Document Type
- Article (1110)
- Doctoral Thesis (727)
- Book (46)
- Preprint (31)
- Contribution to a Periodical (14)
- Conference Proceeding (11)
- Report (11)
- Review (9)
- diplomthesis (3)
- Part of a Book (2)
Has Fulltext
- yes (1970) (remove)
Is part of the Bibliography
- no (1970)
Keywords
- crystal structure (37)
- Crystal Structure (25)
- Synthesis (15)
- ESR Spectra (14)
- RNA (14)
- NMR-Spektroskopie (12)
- hydrogen bonding (11)
- IR Spectra (10)
- NMR spectroscopy (10)
- RNS (9)
Institute
- Biochemie und Chemie (1970) (remove)
Small molecule drug discovery is strongly supported by biophysical data. In the reach of this thesis, cell free protein expression was used to produce human target proteins for ligand binding assays using Surface Plasmon Resonance spectroscopy (SPR). In the second step the binding and interaction characteristics of small molecules and fragments were analyzed using Nuclear Magnetic Resonance spectroscopy (NMR).
The first target protein was the human acid sensing channel 1 (ASIC1a). ASIC1a was expressed in a cell free expression system based on E.coli lysate. To optimize the expression, several parameters including fusion tags, ion concentrations and different hydrophobic environments were tested.
The adaption of the folding environment for ASIC1a needed more optimization, because it is a very challenging target to express in an in vitro system. Three different expression modes were employed to find a suitable folding environment.
SPR binding studies with ASIC1a were performed with chicken ASIC1a expressed in insect cells. The immobilization of cASIC1a and the used buffer conditions were tested using Psalmotoxin 1, a naturally occurring peptide venom which binds strong to the trimeric form of ASIC1a. Compound characterization experiments were performed with a variety of different ligands including amiloride, a general blocker of the whole ENaC protein family. None of the used ligands showed titration curves that would match a simple 1:1 binding model. The experiments either show no binding signal or signal that could be interpreted as unspecific binding. Even amiloride that should be binding the protein shows no signals that fit a simple binding model.
Another target protein that was investigated is the soluble prolyl cis/trans isomerase Cyclophilin D (or peptidyl prolyl isomerase F – PPIF). This protein is involved in the regulation of the mitochondrial permeability transition pore and therefore a potential drug target to treat neurodegenerative diseases. Small molecule binding was tested with CypD using SPR. Following the kinetic analysis of small molecule ligands, the binding position of different binding fragments was analyzed. These fragments originated from a SPR based fragment screen and gave no co-crystal structures with CypD. Therefore NMR was used to investigate the binding position of these fragments. An analysis of the chemical shift perturbations upon ligand addition revealed that the NMR analysis was in line with the results gathered by x-ray crystallography. The fragments with unknown binding position however, all bind to a specific patch slightly outside the binding pocket.
The ligand CL1 showed a special behavior in the NMR experiments. Upon addition to CypD, it produced large shifts on many signals of the protein, accompanied by a severe line broadening. The shift perturbations were so numerous and large that the spectrum had to be reassigned in complex with the ligand. Triple selective labeling was applied to allow a fast and nearly complete signal assignment. The possibility to use highly sophisticated labeling schemes, is one of the advantages of cell free protein expression. After the assignment of the complex spectrum, the chemical shift perturbations were analyzed and quantified. The residues showing the strongest CSPs are also identified in the crystal structure to be involved in the binding of CL1, giving a consistent picture. The numerous and large shift perturbations, produced by CL1 led to the assumption, that the ligand induces a conformational change in CypD, which is not represented in the co-crystal structure. This conformational change was characterized by a NMR based structure determination. CypD apo yielded a defined bundle, whose folded regions overlap well with the corresponding crystal structure.
For the calculation of the CypD-CL1 complex structure, the sidechain resonances were assigned using an automated assignment approach with the software FLYA. The calculation of the CypD-CL1 complex structure did not result in a defined bundle. While parts of the protein converge in a well folded state, the region around the active site shows no defined folding. Careful analysis of the structure calculation suggests that the problems during structure calculation did not originate from an incorrect resonance assignment, but rather from a lack of NOE crosspeaks. This might be due to a broadening of the corresponding NOE crosspeaks or the coexistence of many different conformations. This leads to the conclusion, that the protein conformation is not defined by the NMR data and could be in a dynamic interchange between multiple structures.
This hypothesis is supported by other observations. The line broadening of the signals in the complex is pronounced in the area around the active site and the substrate binding pocket, hinting to a connection between catalytic activity and protein dynamics. In addition many NMR signals are sensitive to changes in the measurement field strength and the temperature. This field dependent signal splitting suggests dynamic conformational changes in the protein between at least two different conformations on a millisecond timescale.
The current working model is that CL1 binds to CypD and induces the catalytic cycle and the connected conformational changes in CypD. As a result the proline like moiety in CL1 is constantly switching between the cis and the trans conformation. Due to the high affinity of CL1, the inhibitor does not leave the binding pocket after successful catalysis, but stays bound in the pocket stimulating further catalytic cycles. These findings as well as the working model are well in line with data published for Cyclophilin A, another member of the cyclophilin family, thereby supporting the model.
During the last decade of the 20th century, the field of mass spectrometry has seen a revolutionary change in its application and scope. The introduction of soft ionization methods for the analysis of biological molecules has expanded the area of mass spectrometry from its early roots in the analysis of inorganic and organic species into the fields of biology and medicine.
Today, the use of the mass spectrometry is extended to a wide range of applications in biotechnology and pharmaceutical industry, in geological, environmental and clinical research. In biochemistry, the principles of mass spectrometry are, however, broadly applicable in accurate molecular weight determination, reaction monitoring, amino acid sequencing, oligonucleotide sequencing and protein structure.
In order to carry out their biological activities, proteins interact most often to each other and form transient or stable complexes. In addition, some proteins specifically interact also with other proteins or with non-protein molecules, such as DNA, RNA or metabolites, these interactions being critical for their function. Hence, defining the composition of protein complexes, as well as understanding how protein complexes are assembled and regulated yield invaluable insights into protein function. Coupled with an isolation technique to purify a specific protein complex of interest, mass spectrometry can rapidly and reliably identify the components of complexes. In addition, quantitative MS techniques offer the possibility of studying dynamically regulated interactions....
Die Biosynthese der Fettsäuren (FS) ist in Eukaryoten und Bakterien ein hochkonserviert zentraler Stoffwechselweg, der in zwei strukturell verschiedenen Systemen ausgeführt wird. Die meisten Bakterien, Parasiten, Pflanzen und Mitochondrien nutzen ein Fettsäuresesynthase Typ-II (FAS-II) System. Bei FAS II Systemen sind alle katalytischen Domänen separate lösliche Proteine. In Eukaryoten wie auch den Bakterien Corynebakteria, Mycobakteria, Nocardia (Klasse der CMN Bakterien) liegen die katalytischen Domänen fusioniert auf einer Polypeptidkette vor, die zu einem Multienzymkomplex der Fettsäuresynthase Typ I (FAS-I) assemblieren. Die Architektur der FAS-I zeigt große Unterschiede; die X förmige Säuger-FAS-I (Maier et al., 2006), sowie die fassartigen Enzyme der Pilz FAS-I (Jenni et al., 2007; Leibundgut et al., 2007; Lomakin et al., 2007; Johansson et al., 2008) und der bakteriellen FAS-I (Boehringer et al., 2013; Ciccarelli et al., 2013). Zwischen Pilz- und bakterieller FAS-I gibt es trotz des ähnlichen Aufbaus bedeutende Unterschiede. Mycobakterium tuberculosis, der Auslöser von Tuberkulose (TB), an der jährlich über eine Million Menschen weltweit sterben (WHO, 2014), synthetisiert durch eine Symbiose von FAS-I, FAS-II und der Polyketidsynthase-13 Mykolsäuren. Durch die Mykolsäuren ist M. tuberculosis resistent gegen äußere Einflüsse. FAS-I ist in die Synthese der Vorstufen der Mykolsäuren involviert. Sie stellt im Kampf gegen TB ein potentielles Inhibierungstarget dar.
Strukturell war die bakterielle FAS-I beim Beginn der vorliegenden Arbeit, nur durch negative-stain-Elektronenmikroskopie (EM) Aufnahmen aus dem Jahr 1982 charakterisiert (Morishima et al., 1982). In dieser Arbeit konnte die bakteriellen FAS I aus M. tuberculosis (MtFAS), sowie Corynebacterium ammoniagenes (CaFAS) und Corynebacterium efficiens (CeFAS) strukturell untersucht werden. Dies geschah mit den Methoden negative-stain-EM, Einzelmolekül-Cryo-EM (Cryo-EM), Cryo EM Tomographie (CET) und Röntgenkristallographie.
Anhand von CeFAS-Kristallen konnte erstmals durch Röntgenkristallographie die Struktur einer bakteriellen FAS-I bestimmt werden. Zudem wurde die hohe konformationelle Flexibilität der bakteriellen FAS-I mit mehreren Methoden gezeigt. Für die CaFAS konnte mit Cryo-EM initiale Prozesse der Proteinkristallbildung abgebildet werden.
A novel series of ribonucleosides of 1,2,3-triazolylbenzyl-aminophosphonates was synthesized through the Kabachnik–Fields reaction using I2 as catalyst followed by copper-catalyzed cycloaddition of the azide–alkyne reaction (CuAAC). All structures of the newly prepared compounds were characterized by 1H NMR, 13C NMR, and HRMS spectra. The structures of 2e, 2f, 3d, and 3g were further confirmed by X-ray diffraction analysis. These compounds were tested against various strains of DNA and RNA viruses; compounds 4b and 4c showed a modest inhibitory activity against respiratory syncytial virus (RSV) and compound 4h displayed modest inhibitory activity against Coxsackie virus B4.
Rotary adenosine triphosphate (ATP)ases are ubiquitous, membrane-bound enzyme complexes involved in biological energy conversion. The first subtype, the so-called F1Fo ATP synthase, predominantly functions as an ATP synthesizing machinery in most bacteria, mitochondria and chloroplasts. The vacuolar subtype of enzyme, the V1Vo ATPase, operates as an ATP driven ion pump in eukaryotic membranes. The subtype found in archaea and some bacteria is called A1Ao ATP (synth)ase and is capable of working in both directions either to synthesize ATP or to generate an ion motive force by consuming the same.
All the three above-mentioned subtypes of rotary ATPases work as nanomolecular machines sharing a conserved mechanism to perform the energy conservation process. The simplest form of these enzymes is the bacterial F1Fo ATP synthase. Here, ions are channelled via the membrane stator subunit a to the rotor ring of the enzyme. After almost a complete rotation of the ring the ions are released again on the other side of the membrane. This rotation is further transmitted via the central stalk to the soluble part of the enzyme, the F1-complex, where conformational changes within the nucleotide binding sites result in the synthesis of ATP from ADP and Pi.
The rotor or c-ring of the enzyme is the key protein complex in mediating transmembrane ion translocation. Several structural and biochemical methods have been applied in the past years to study the rotor rings from many different organisms. The results revealed that the stoichiometry of a c-ring of a given species is constant while it can vary between different species within a range of 8 to 15 c subunits. The c-ring stoichiometry determines directly the number of ions transported through Fo per rotation whereby three molecules of ATP are concurrently synthesized in the water-soluble F1 headgroup. Hence the number of c subunits has an important influence on the bioenergetics of the corresponding enzyme and thus the entire organism.
The c-ring of a rotary ATPase is able to specifically bind either protons (H+) or sodium ions (Na+) as the coupling ion for the enzyme. Several structures are already available revealing the coordination network of both types of rotor rings. In each case ion binding includes a highly-conserved carboxylic acid residue (glutamate or aspartate), in addition to a more varying combination of amino acid residues, whereby Na+ coordination is structurally more demanding than H+ binding.
In the first part of my PhD thesis, I aimed to characterize the F1Fo ATP synthase rotor ring of the opportunistic pathogenic bacterium Fusobacterium nucleatum on a functional and structural level. F. nucleatum is an anaerobic bacterium which uses peptides and amino acids as a primary energy source. It is one of the most frequently occuring bacteria in human body infections and involved in human periodontal diseases.
The protein complex was heterologously expressed within a hybrid ATP synthase in Escherichia coli and purified without an affinity tag for further analysis. Two high resolution X-ray structures of the c-ring were solved at low (5.3) and high (8.7) pH to 2.2 and 2.64 Å, respectively. In both structures, the conserved glutamate is in an ion-locked conformation, revealing that the conformational state of the ion binding carboxylate is not depending on the pH of the crystallization condition, which is in good agreement with previous structural and biochemical studies of other c-rings.
A Na+ ion is present within the c-ring binding site and directly coordinated by four amino acid residues and a structural water molecule. Remarkably, the Na+ is bound by two glutamate residues instead of one as is the case in the I. tartaricus Na+ binding c-ring, of which the first high resolution X-ray structure of a c-ring has been solved in 2005. Thus, a new type of Na+ coordination in an ATP synthase rotor ring with a two-carboxylate ion binding motif is described here, which also occurs in other bacteria, including several pathogens. Na+ specificity of the investigated c-ring was further confirmed by a competitive biochemical labeling reaction performed with a fluorescent ATP synthase inhibitor molecule (N-cyclohexyl-N`-[4(dimethylamino)-α-naphtyl] carbodiimide, NCD-4).
We furthermore complemented our functional and structural data of the F. nucleatum c-ring by computational studies to explore the ion translocation mechanism of this enzyme in more details. We therefore analyzed the protonation state of the second, additional glutamate in the ion binding site. Molecular dynamics (MD) simulations and free-energy calculations indicated that this glutamate is constitutively protonated, in the ion-locked as well as in a simulated, more hydrated open-conformation of the ion binding glutamate as when it is travelling through the a/c-ring interface upon c-ring rotation.
During my thesis, I worked on two different membrane proteins. One is a bacterial secondary transporter and the second is a human mitochondrial calcium channel.
The first part of my thesis involves the structural and biochemical characterization of an L-carnitine/ γ-butyrobetaine antiporter from bacteria called CaiT. The aim of the project was to understand the Na+ independence of CaiT and to determine the crystal structures of CaiT in different conformations to expand the mechanistic understanding of substrate/ product antiport in CaiT.
The study revealed how a positively charged amino acid side chain (arginine 262) in CaiT could structurally and functionally mimic a sodium ion. Additionally, various crystal structures of CaiT obtained in this study demonstrate that the central substrate-binding site is highly dynamic and can accommodate the substrate in various orientations.
In the second part of my thesis, I was able to optimize the expression and purification conditions for the human mitochondrial calcium uniporter or the MCU. Understanding how this channel functions can help us unravel the mechanism of calcium uptake by mitochondria. Secondary structure prediction analysis in combination with mass spectrometry of degraded MCU products obtained during the purification of the full-length protein led to the identification of a stable MCU construct. This study resulted in the successful purification of milligram quantities of stable MCU protein for the first time. Further optimization may be required to obtain more homogenous protein that is amenable for crystallization.
Protein folding in cells is regulated by networks of chaperones, including the heat shock protein 70 (Hsp70) system, which consists of the Hsp40 cochaperone and a nucleotide exchange factor. Hsp40 mediates complex formation between Hsp70 and client proteins prior to interaction with Hsp90. We used mass spectrometry (MS) to monitor assemblies formed between eukaryotic Hsp90/Hsp70/Hsp40, Hop, p23, and a client protein, a fragment of the glucocorticoid receptor (GR). We found that Hsp40 promotes interactions between the client and Hsp70, and facilitates dimerization of monomeric Hsp70. This dimerization is antiparallel, stabilized by post-translational modifications (PTMs), and maintained in the stable heterohexameric client-loading complex Hsp902Hsp702HopGR identified here. Addition of p23 to this client-loading complex induces transfer of GR onto Hsp90 and leads to expulsion of Hop and Hsp70. Based on these results, we propose that Hsp70 antiparallel dimerization, stabilized by PTMs, positions the client for transfer from Hsp70 to Hsp90.
Habituation ist eine der einfachsten Formen des Gedächtnisses. Hierbei handelt es sich um die erlerne Gewöhnung an einen harmlosen Reiz. Dies bedeutet, dass nach mehrfacher wiederholter Repräsentation eines harmlosen Reizes die Reaktion darauf stetig abnimmt, bis sie völlig zum erliegen kommt. Je nach Trainingsprotokoll kann diese Gewöhnung bis zu mehren Tagen andauern. Habituation ist hoch konserviert und ein Verhaltensmuster, dass auch bei sehr einfachen vielzelligen Organismen zu finden ist und untersucht werden kann. Zur Untersuchung des Zusammenspiels innerhalb eines neuronalen Netzwerkes, welches für die Habituation des Rückzugsreflexes (Ausweichreaktion nach Berührung) verantwortlich ist wurde hier der Fadenwurm Caenohabditis elegans (C. elegans) als Modell Organismus verwendet. Aufgrund seines einfachen, nur 302 Zellen umfassenden, Nervensystems eignet sich C. elegans sehr gut für Grundlagenforschung in diesem Bereich. Das neuronale Netzwerk, das verantwortlich ist für den Rückzugsreflex ist in drei Ebenen organisiert. Wahrgenommen wird der Reiz von sensorischen Neuronen (ASH, ALM, AVM, PLM, PVM). Die Weiterleitung erfolgt über verschiedene Interneuronen (AVA, AVB, AD, AVE, PVC) hin zu den Motorneuronen, welche die Muskeln enervieren und somit die Reaktion auf den in erster Ebenen wahrgenommen Reiz auslösen.
Mit Hilfe von optogenetischen Werkzeugen wurde hier Untersucht welche Rolle einzelne Zellen innerhalb dieses Netzwerkes innehaben und an welcher Stelle innerhalb des Netzwerkes die kurzzeitige Habituation des Reizes, nach einem Einfachen Lernprotokoll stattfindet. Zuerst musste eine Möglichkeit gefunden werden die zur Verfügung stehenden optogenetischen Werkzeuge zellspezifisch zu exprimieren. In dieser Arbeit wurden hierfür Rekombinasesysteme verwendet, die es ermöglichten zur Expression eine Kombination aus 2 verschiedenen Promotoren zu verwenden. Beide Promotoren dürfen hierbei nur in einer Zelle, der Zielzelle, überlappen. Es konnte zellspezifische Expression des Kationenkanals Chanelrhodopsin 2 (ChR2) in den beiden Zellparen AVAL/R und ASHL/R (nimmt aversive Reize wahr) erreicht werden.
Zur Untersuchung der Habituation wurde zusätzlich noch ein Wurmstamm verwendet, welcher ChR2 unter dem mec-4 Promotor exprimiert. ChR2 ist hier in den Mechanorezeptorneuronen (MRN) ALM, AVM, PLM und PVM exprimiert. Die hier durchgeführten Experimente deuten darauf hin das den MRNs die Größte Rolle bei der Ausbildung einer Habituation zukommt. Es gibt jedoch auch Hinweise darauf, dass AVA zusätzlich eine Rolle spielt.
Im weiteren Verlauf der Arbeit wurde die Rolle von AVA genauer untersucht. AVA gilt als der Hauptsignalgeber für eine Rückwärtsbewegung (spontan und nach Reizempfang). Es konnte gezeigt werden dass eine Unterbrechung der ’Gap Junktionen’ zwischen AVA und PVC eine stärkere Reaktion zur Folge haben. AVA scheint also durch PVC inhibiert zu werden. Ebenfalls mit AVA direkt interagierende Neuronen sind AVD und AVE. Mit den hier zur Verfügung stehenden Mitteln konnte die genaue Modulation von AVA durch diese Zellen jedoch nicht gezeigt werden.
In dieser Arbeit konnte der Grundstein für eine funktionale Aufklärung des Nervensystems von C. elegans gelegt werden. Vor allem durch die Möglichkeit der zellspezifischen Expression kann es zukünftig gelingen das Zusammenspiel der einzelnen Nervenzellen und ihren Anteil an einem bestimmtem Verhalten zu Untersuchen.
Pflanzen, aber auch einige Bakterien und Archäen verfügen über hocheffiziente Mechanismen, Licht in Energie umzuwandeln. Photovoltaik-Zellen reichen an die Perfektion dieser natürlichen Systeme noch lange nicht heran. Deshalb versuchen Forscher, mit ultraschnellen spektroskopischen Methoden der Natur in die Karten zu schauen und von ihr zu lernen.
Die Glühbirne hat ausgedient. Auch Energiesparlampen sind nur eine Übergangslösung. Große Hoffnungen richten sich auf organische Leuchtdioden, zumal man daraus auch großflächige und biegsame Displays und Flachbildschirme herstellen kann. Für eines der größten Probleme, das Ausbleichen der blauen Leuchtstoffe, findet man immer bessere Lösungen. Anwendungen, die heute noch wie Science-Fiction klingen, rücken damit in erreichbare Nähe.
Der Auflösung mikroskopischer Verfahren ist durch die Beugungsgrenze eine natürliche Schranke gesetzt. Strukturen, die näher als die halbe Wellenlänge des verwendeten Lichts zusammenliegen, können nicht aufgelöst werden. Doch Forscher haben einen Weg gefunden, diese Grenze zu umgehen. Die entstehenden Bilder ähneln dem Pointillismus in der Malerei.
Introduction: Interferon alpha (IFNα) is routinely used in the clinical practice for adjuvant systemic melanoma therapy. Understanding the molecular mechanism of IFNα effects and prediction of response in the IFNα therapy regime allows initiation and continuation of IFNα treatment for responder and exclusion of non-responder to avoid therapy inefficacy and side-effects. The transporter protein associated with antigen processing-1 (TAP1) is part of the MHC class I peptide-loading complex, and important for antigen presentation in tumor and antigen presenting cells. In the context of personalized medicine, we address this potential biomarker TAP1 as a target of IFNα signalling.
Results: We could show that IFNα upregulates TAP1 expression in peripheral blood mononuclear cells (PBMCs) of patients with malignant melanoma receiving adjuvant high-dose immunotherapy. IFNα also induced expression of TAP1 in mouse blood and tumor tissue and suppressed the formation of melanoma metastasis in an in vivo B16 tumor model. Besides its expression, TAP binding affinity and transport activity is induced by IFNα in human monocytic THP1 cells. Furthermore, our data revealed that IFNα clearly activates phosphorylation of STAT1 and STAT3 in THP1 and A375 melanoma cells. Inhibition of Janus kinases abrogates the IFNα-induced TAP1 expression. These results suggest that the JAK/STAT pathway is a crucial mediator for TAP1 expression elicited by IFNα treatment.
Conclusion: We suppose that silencing of TAP1 expression provides tumor cells with a mechanism to escape cytotoxic T-lymphocyte recognition. The observed benefit of IFNα treatment could be mediated by the shown dual effect of TAP1 upregulation in antigen presenting cells on the one hand, and of TAP1 upregulation in ‘silent’ metastatic melanoma cells on the other hand. In conclusion, this work contributes to a better understanding of the mode of action of IFNα which is essential to identify markers to predict, assess and monitor therapeutic response of IFNα treatment in the future.
Recent studies indicate that the abnormal microenvironment of tumors may play a critical role in carcinogenesis, including lung cancer. We comprehensively assessed the number of stromal cells, especially immune/inflammatory cells, in lung cancer and evaluated their infiltration in cancers of different stages, types and metastatic characteristics potential. Immunohistochemical analysis of lung cancer tissue arrays containing normal and lung cancer sections was performed. This analysis was combined with cyto-/histomorphological assessment and quantification of cells to classify/subclassify tumors accurately and to perform a high throughput analysis of stromal cell composition in different types of lung cancer. In human lung cancer sections we observed a significant elevation/infiltration of total-T lymphocytes (CD3+), cytotoxic-T cells (CD8+), T-helper cells (CD4+), B cells (CD20+), macrophages (CD68+), mast cells (CD117+), mononuclear cells (CD11c+), plasma cells, activated-T cells (MUM1+), B cells, myeloid cells (PD1+) and neutrophilic granulocytes (myeloperoxidase+) compared with healthy donor specimens. We observed all of these immune cell markers in different types of lung cancers including squamous cell carcinoma, adenocarcinoma, adenosquamous cell carcinoma, small cell carcinoma, papillary adenocarcinoma, metastatic adenocarcinoma, and bronchioloalveolar carcinoma. The numbers of all tumor-associated immune cells (except MUM1+ cells) in stage III cancer specimens was significantly greater than those in stage I samples. We observed substantial stage-dependent immune cell infiltration in human lung tumors suggesting that the tumor microenvironment plays a critical role during lung carcinogenesis. Strategies for therapeutic interference with lung cancer microenvironment should consider the complexity of its immune cell composition.
The title compound, [Li2(C25H23BN4OP)2], features a centrosymmetric dimeric complex. The four-memberered Li2O2 ring is exactly planar due to symmetry. The Li atom is four-coordinated by two O atoms and by two N atoms of two different pyrazole rings. The dihedral angle between two pyrazole rings bonded to the same B atom is 45.66 (9)°. The B—N—N—Li—N—N metalla ring adopts a boat conformation. The crystal packing is stabilized by van der Waals interactions only.
The structure of the title compound, C8H16N4, which consists of four fused seven-membered rings, has been redetermined at 173 K. This redetermination corrects the orientation of two H atoms, which were located at unrealistic positions in the original room-temperature study [Murray-Rust (1974[Murray-Rust, P. (1974). J. Chem. Soc. Perkin Trans. 2, pp. 1136-1141.]). J. Chem. Soc. Perkin Trans. 2, pp. 1136–1141]. The complete molecule is generated by -42m symmetry, with one quarter of a molecule [one N atom (site symmetry m), two C atoms (one with site symmetry m and the other with site symmetry 2) and two H atoms] in the asymmetric unit. No directional interactions beyond van der Waals contacts are apparent in the crystal structure.
Single crystals of the title compound, C10H11NO4, an intermediate in the industrial synthesis of yellow azo pigments, were obtained from the industrial production. The molecules crystallize as centrosymmetic dimers connected by two symmetry-related N—H⋯O=C hydrogen bonds. Each molecule also contains an intramolecular N—H⋯O=C hydrogen bond. The dimers form stacks along the a-axis direction. Neighbouring stacks are arranged into a herringbone structure.
In the title compound, C40H76Si, the Si atom is located on a special position of site symmetry -4. Thus, there is just a quarter of a molecule in the asymmetric unit. The C=C double bonds exhibit a trans configuration. The Si atom and the tert-butyl group are located on the same side of the plane formed by the C=C double bond and its four substituents. The crystal packing shows no short contacts between the molecules and despite the low crystal density (0.980 Mg m−3), there are no significant voids in the structure.
In the title compound, C19H24N2O2, a di-Mannich base derived from 2-methylphenol and 1,3,6,8-tetraazatricyclo[4.4.1.13,8]dodecane, the imidazolidine ring adopts a twist conformation, with a twist about the ring N—C bond [C—N—C—C torsion angle = −44.34 (14)°]. The two 2-hydroxy-3-methylbenzyl groups are located in trans positions with respect to the imidazolidine fragment. The structure displays two intramolecular O—H⋯N hydrogen bonds, which each form an S(6) ring motif. In the crystal, the molecules are linked by weak C—H⋯O interactions with a bifurcated acceptor, forming a three-dimensional network.
The title compound, C12H20N4O, undergoes a phase transition on cooling. The room-temperature structure is tetragonal (P43212, Z′ = 1), with the methoxybornyl group being extremely disordered. Below 213 K the structure is orthorhombic (P212121, Z′ = 2), with ordered molecules. The two independent molecules (A and B) have very similar conformations; significant differences only occur for the torsion angles about the Cbornyl—Ctetrazole bonds. The independent molecules are approximately related by the pseudo-symmetry relation: xB = −1/4 + yA, yB = 3/4 - xA and zB = 1/4 + zA. In the crystal, molecules are connected by N—H⋯N hydrogen bonds between the tetrazole groups, forming a pseudo-43 helix parallel to the c-axis direction. The crystal studied was a merohedral twin with a refined twin fraction value of 0.231 (2).
The title molecule, C34H28I4·4C6H6, has crystallographic 4 symmetry and crystallizes with four symmetry-related benzene solvent molecules. The phenyl group is eclipsed with one of the adamantane C—C bonds. The tetraphenyladamantane units and the benzene solvent molecules are connected by weak intermolecular phenyl–benzene C—H⋯π and benzene–benzene C—H⋯π interactions. In the crystal, molecules are linked along the c-axis direction via the iodophenyl groups by a combination of weak intermolecular I⋯I [3.944 (1) Å] and I⋯π(phenyl) [3.608 (6) and 3.692 (5) Å] interactions.
Zur Untersuchung der Eigenschaften organischer Halbleiter sollte die Ultrareinigung organischer Materialien durch Zonenschmelzen ermöglicht werden und anschließend dieses Verfahren auf einen neuen molekularen n-Halbleiter, Perfluoranthracen, angewendet werden. Ein Großteil der vorliegenden Arbeit beschäftigte sich daher mit der Konstruktion einer Zonenschmelze. Diese sollte in der Lage sein, laborübliche Mengen organischer Materialien zu reinigen (ca. 0,5-5 g). Ein Eigenbau wurde in Angriff genommen, um eine optimale Anpassung an die zu erwartenden Aufgabenstellungen zu erreichen. Daher wurde das System in einer modularen Bauweise konzipiert, sodass einzelne oder mehrere Heizzonen verwendet werden können und die Apparatur auch später beliebig erweitert werden kann. Zunächst mussten Erfahrungen mit der Wärmezufuhr und Kühlung gesammelt werden und ein verlässlicher Zugmechanismus entwickelt werden, der die Probe in kontrollierter, langsamer Weise durch die Apparatur bewegt. Ein grosses Problem stellte das Bersten der gläsernen Probenbehältnisse beim Zonenschmelzen einiger Substanzen dar. Nach dem erfolgreichen Einsatz verschiedener Puffermaterialien wurde schliesslich ein apparativer Aufbau entwickelt, der auf eine aktive Kühlung verzichtete. Hierdurch konnte die unkontrollierte Sublimation unterbunden werden und das Bersten der Probenbehältnisse wurde unterdrückt. Gleichzeitig musste jedoch sichergestellt werden, dass die Effektivität des Zonenschmelzen auch ohne den Einsatz grosser Temperaturgradienten gegeben war. Die Reinigung verschiedener kommerziell verfügbarer Substanzen wurde getestet und gleichzeitig die Analytik der organischen Verunreinigungen mittels Gaschromatographie im Arbeitskreis etabliert. Das Zonenschmelzen ermöglichte schließlich die Reinigung von Anthracen bis auf 99,97%. In Dibenzothiophen konnten der Anteil der Nebenkomponenten unter die Nachweisgrenze verringert werden. Nach der Herstellung von Perfluoranthracen wurden unterschiedliche Methoden zur Reinigung getestet und schließlich das Zonenschmelzen angewendet. Es war möglich, kleinere Mengen an Perfluoranthracen in einer Reinheit von bis zu 99,11% zu isolieren, was durch reguläre Reinigungsverfahren wie Umkristallisation oder Sublimation nicht erreicht werden konnte. Dennoch limitierte die thermische Instabilität des Materials die Effektivität des Zonenschmelzens.
Weiterhin wurden die optische und elektrochemische Bandlücke von Perfluoranthracen untersucht, um Aussagen über die mögliche Anwendung als n-Halbleiter treffen zu können. Es wurde eine optische Bandlücke von 3,08 eV und eine elektrochemische Bandlücke von 2,82 eV ermittelt. Im Vergleich zu Anthracen wurden niedriger liegende Grenzorbitale bestimmt, was ein Einbringen von Elektronen in das energetisch niedrigste unbesetzte Molekülorbital (LUMO) und somit n-Halbleitung vereinfachen könnte. Schließlich wurde untersucht, ob sich durch die äquimolare Mischung von Anthracen und Perfluoranthracen Mischkristalle herstellen lassen, die Charge-Transfer-Eigenschaften (CT) und eine hohe elektrische Leitfähigkeit aufweisen würden. Hierzu mussten zunächst ausreichend grosse Einkristalle gezüchtet werden, von denen anschliessend die Röntgenkristallstruktur bestimmt wurde. Das einkristalline Material zeigte eine gemischt gestapelte Anordnung (siehe Abbildung 0.2), wie sie für andere Systeme, beispielsweise Benzol/Hexafluorbenzol, bekannt ist. In feldstärkenabhängigen und temperaturabhängigen Messungen wurden danach die elektrischen Eigenschaften des Materials charakterisiert. Es konnten keine Hinweise für CT-Eigenschaften gefunden werden. Dennoch besitzt der Mischkristall im Vergleich zu Anthracen eine etwa 10 12 -fach höhere Leitfähigkeit und erreicht Werte guter anorganischer Halbleiter. Das temperaturabhängige Verhalten selbst zeigt aber keine typisch halbleitenden Charakteristiken, da für die thermisch angeregte Zunahme der Ladungsträgerkonzentration im untersuchten Mischkristall kein lineares Verhalten im Arrhenius-Plot gefunden wurde. Die genauen Leitungsmechanismen bedürfen weiterer Untersuchungen. In nachfolgenden Experimenten könnte die mögliche Anwendbarkeit in elektronischen Anwendungen geklärt werden.
The title compound, C37H67NO13·2C2H6OS·1.43H2O, is a macrolide antibiotic with better solubility and better dermal penetration abilities than erythromycin A itself. The asymmetric unit of this form contains one erythromycin A molecule, two dimethyl sulfoxide (DMSO) solvent molecules, a fully occupied water molecule and a partially occupied water molecule with an occupancy factor of 0.432 (11). The 14-membered ring of the erythronolide fragment has a conformation which differs considerably from that in erythromycin A dihydrate [Stephenson, Stowell, Toma, Pfeiffer & Byrn (1997[Stephenson, G. A., Stowell, J. G., Toma, P. H., Pfeiffer, R. R. & Byrn, S. R. (1997). J. Pharm. Sci. 86, 1239-1244.]). J. Pharm. Sci. 86, 1239–1244]. One of the two DMSO molecules is disordered over two orientations; the orientation depends on the presence or absence of the second, partially occupied, water molecule. In the crystal, erythromycin molecules are connected by O—H⋯O hydrogen bonds involving the hydroxy groups and the fully occupied water molecule to form layers parallel to (010). These layers are connected along the b-axis direction only by a possible hydrogen-bonding contact involving the partially occupied water molecule.
The crystal structure of the title compound, C25H24N2O2, at 173 K has monoclinic (C2/c) symmetry. The molecule is located on a crystallographic twofold rotation axis with only half a molecule in the asymmetric unit. The imidazolidine ring adopts a twist conformation, with a twist about the ring C—C bond. The crystal structure shows the anticlinal disposition of the two (2-hydroxynaphthalen-1-yl)methyl substituents of the imidazolidine ring. The structure displays two intramolecular O—H⋯N hydrogen bonds, each forming an S(6) ring motif.
In the title salt, [Ag(C27H36N2)2]Cl·C4H8O, the AgI atom is coordinated by two 1,3-bis(2,6-dimethylphenyl)imidazol-2-ylidene ligands. The imidazole rings are inclined to one another by 46.69 (13)° and the benzene rings in each ligand are almost normal to the imdazole ring to which they are attached, with dihedral angles varying from 82.39 (13) to 88.27 (12)°. There are C—H⋯π interactions present in the cation, involving the two ligands, and the solvent molecule is linked to the cation via a C—H⋯O hydrogen bond. In the crystal, molecules are linked by trifurcated C—H⋯(Cl,Cl,Cl) hydrogen bonds, forming slabs parallel to (101). One isopropyl group is disordered over two sets of sites with an occupancy ratio of 0.447 (17):0.553 (17) and the THF molecule is disordered over two positions with an occupancy ratio of 0.589 (6):0.411 (6).
In the title ternary co-crystalline adduct, C7H14N4·2C6H5NO3, molecules are linked by two intermolecular O—H⋯N hydrogen bonds, forming a tricomponent aggregates in the asymmetric unit. The hydrogen-bond formation to one of the N atoms is enough to induce structural stereoelectronic effects in the normal donor→acceptor direction. In the title adduct, the two independent nitrophenol molecules are essentially planar, with maximum deviations of 0.0157 (13) and 0.0039 (13) Å. The dihedral angles between the planes of the nitro group and the attached benzene rings are 4.04 (17) and 5.79 (17)°. In the crystal, aggregates are connected by C—H⋯O hydrogen bonds, forming a supramolecular dimer enclosing an R66(32) ring motif. Additional C—H⋯O intermolecular hydrogen-bonding interactions form a second supramolecular inversion dimer with an R22(10) motif. These units are linked via C—H⋯O and C—H⋯N hydrogen bonds, forming a three-dimensional network.
In der vorliegenden Arbeit wurde ein Flugzeitmassenspektrometer (TOF-MS) für die Messung von halogenierten Spurengasen charakterisiert und das verwendete analytische System optimiert. Ein TOF-MS hat den Vorteil, dass es die volle Masseninformation aufzeichnet. Dadurch ist es möglich, auch im Nachhinein Substanzen zu identifizieren und retrospektiv auszuwerten. Eine retrospektive Auswertung kann helfen, Auswirkungen auf die Atmosphäre besser abschätzen zu können. Aus diesem Grund wurde mit Hilfe des TOF-MS ein digitales Datenarchiv durch regelmäßige Messungen von Luftproben, die am Taunus Observatorium auf dem Kleinen Feldberg genommen wurden, initialisiert. Durch die Wahl des Taunus Observatoriums werden in unmittelbarer Nähe des industriellen Ballungsraums Rhein-Main auf der Nordhemisphäre Luftproben genommen, wodurch die Wahrscheinlichkeit erhöht wird, unbekannte Substanzen in erhöhter Konzentration zu messen.
Bevor das TOF-MS jedoch für die Initialisierung des Datenarchivs verwendet werden konnte, wurde es charakterisiert und mit einem, für die Analyse von halogenierten Kohlenwasserstoffen etablierten QP-MS verglichen. Um beide Detektoren vergleichen zu können, erfolgte die Probenaufgabe, Probenaufkonzentrierung und die Separation der Probe im Gaschromatographen innerhalb eines gemeinsamen Systems. Nach der Separation im GC teilt sich der Trägergasfluss auf. Die Charakterisierung des TOF-MS und der Vergleich mit dem QP-MS umfasst die Auswertung der Daten, die Messpräzision, die Linearität, die Sensitivität der Detektoren, die Massenauflösung und die Massenachsenbestimmungsgenauigkeit.
Hinsichtlich der Messpräzision liegen beide Massenspektrometer, wie ermittelt auf dem selben Niveau, wodurch sie auch sehr geringe Variabilitäten in den Mischungsverhältnissen von halogenierten Kohlenwasserstoffen aufzeichnen können.
Die Linearität der Detektoren ist substanzspezifisch. Während das QP-MS in Übereinstimmung mit bereits literaturbekannter Eigenschaft, einen sehr großen linearen Bereich aufweist, zeigt das hier verwendete TOF-MS für 2/3 aller ausgewerteter Substanzen starke substanz- und fragmentabhängig Nichtlinearitäten. Das nichtlineare Verhalten des Detektors des TOF-MS zeigt sich auch bei den Messvergleichen, wobei jedoch nur signifikante Abweichungen bei sehr hohen und sehr niedrig gemessenen Mischungsverhältnissen beobachtet wurden. Diese starke Nichtlinearität stellt eine große Einschränkung für eine retrospektive Auswertung unbekannter Substanzen dar, da deren Verlauf nur qualitativ nicht aber quantitativ dargestellt werden kann.
Die Massenauflösung liegt beim TOF-MS bei 1000 mit einer Massenachsenbestimmungsgenauigkeit zwischen 50-170~ppm, wodurch es dem QP-MS, welches nur Einheitsauflösung vorweist, weit überlegen ist. Mit dieser Auflösung und Massenachsenbestimmungsgenauigkeit ist das TOF-MS in der Lage einen halogenierten von einem nichthalogenierten Kohlenwasserstoff quantitativ zu trennen.
Zum Vergleich der Sensitivität der beiden Massenspektrometer wurde das QP-MS in drei verschiedenen Modi betrieben: Zum einen dem SCAN-Modus, dem operationalen SIM-Modus, welcher im regulärem Messbetrieb verwendet wird und mehrere Ionen pro Zeitfenster misst, und dem optimierten SIM-Modus, welcher nur ein Ion der jeweiligen Substanz misst. Das TOF-MS hat die gleiche Sensitivität wie das QP-MS im optimierten SIM-Modus. Das TOF-MS hat eine um den Faktor 3 höhere Sensitivität als das QP-MS im operationalen SIM-Modus und eine um den Faktor 12 höhere Sensitivität als das QP-MS im SCAN-Modus bei den betrachteten Substanzen.
Die Initialisierung des digitalen Datenarchivs wurde im Oktober 2013 mit der Probennahme am Taunus Observatorium begonnen, wobei in der vorliegenden Arbeit der Zeitraum von einem Jahr betrachtet wurde. Es wurden Identifizierungen aus regulären Proben der Taunus Observatoriums-Zeitreihe durchgeführt und so die Substanzen HFC-32, HFC-245fa,HCFC-133a und HFO-1234yf gefunden. Zusätzlich stellte Martin Vollmer (Eidgenössische Material und Prüfgesellschaft) zwei Gasmischungen zu Verfügung für die Identifikation von noch nicht am System vermessenen Substanzen. Somit konnte die Vielfalt an diesem System vermessener Substanzen von 40 auf insgesamt 64 Substanzen erweitert werden.
Von den neu identifizierten Substanzen wurden HFC-227ea, HFC-236fa, HFC-32, HCFO-1233zd, HFO-1234zd, HFO-1234yf, HFC-245fa, HCFC-31, HFC-133a, Isofluran und HFC-112 in der Taunus Observatoriums-Zeitreihe gefunden und rückwirkend aufgearbeitet.
Durch die retrospektive Auswertung ist das TOF-MS für seine charakterisierte Anwendung zum Einsatz gekommen.
The structure of the 1:2 co-crystalline adduct C8H16N4·2C6H5BrO, (I), from the solid-state reaction of 1,3,6,8-tetraazatricyclo[4.4.1.13,8]dodecane (TATD) and 4-bromophenol, has been determined. The asymmetric unit of the title co-crystalline adduct comprises a half molecule of aminal cage polyamine plus a 4-bromophenol molecule. A twofold rotation axis generates the other half of the adduct. The primary inter-species association in the title compound is through two intermolecular O—H⋯N hydrogen bonds. In the crystal, the adducts are linked by weak non-conventional C—H⋯O and C—H⋯Br hydrogen bonds, giving a two-dimensional supramolecular structure parallel to the bc plane.
In the title solvate, C14H12N2O·0.5C6H6, the complete benzene molecule is generated by a crystallographic inversion centre. The dihedral angle between the planes of the benzimidazole moiety and the phenol substituent is 75.28 (3)°. In the crystal, O—H⋯N hydrogen bonds link the molecules into parallel chains propagating along [100]. The molecules are further connected by C—H⋯π interactions.
In the title compound, C23H19NO2, an oxazine Mannich base derivative, the oxazine ring has a half-chair conformation. The 2-hydroxynaphthalen-1-yl substituent is placed in an axial position. There is an intramolecular O-H...N hydrogen bond, forming an S(6) graph-set motif. In the crystal, molecules are connected by a pair of C-H...[pi] interactions into an inversion dimer, which is reinforced by another pair of weak C-H...[pi] interactions. The dimers are linked by a [pi]-[pi] interaction [centroid-centroid distance = 3.6268 (17) Å], consolidating a column along the a axis. Furthermore, the columns interact with each other by a weak C-H...[pi] interaction, generating a three-dimensional network.
In the crystal of the title co-crystalline adduct, C8H16N4·C8H9ClO, (I), prepared by solid-state reaction, the molecules are linked by intermolecular O—H⋯N hydrogen bonds, forming a D motif. The azaadamantane structure in (I) is slightly distorted, with N—CH2—CH2—N torsion angles of 10.4 (3) and −9.0 (3)°. These values differ slightly from the corresponding torsion angles in the free aminal cage (0.0°) and in related co-crystalline adducts, which are not far from a planar geometry and consistent with a D2d molecular symmetry in the tetraazatricyclo structure. The structures also differ in that there is a slight elongation of the N—C bond lengths about the N atom that accepts the hydrogen bond in (I) compared with the other N—C bond lengths. In the crystal, the two molecules are not only linked by a classical O—H⋯N hydrogen bond but are further connected by weak C—H⋯π interactions, forming a two-dimensional supramolecular network parallel to the bc plane.
Starkes Übergewicht und eine damit einhergehende Hypertrophie von Geweben aber auch des Herz-Kreislauf-Systems führen zu einer Reihe von Folgeerkrankungen wie z. B. Diabetes mellitus Typ 2 oder auch Arteriosklerose. Während im Fettgewebe freie Fettsäuren, die von Makrophagen aufgenommen werden, eine entscheidende Rolle spielen, scheint in der Pathogenese von Arteriosklerose die Aufnahme von Fettsäuren aus Lipoproteinpartikeln durch Makrophagen von großer Wichtigkeit zu sein. Ein weiterer Faktor, der durch freie Fettsäuren ausgelöst wird ist ER-Stress. Makrophagen, die zu Triglycerid (TG) reichen Schaumzellen geworden sind, akkumulieren in arteriosklerotischen Läsionen. Der Lipidmetabolismus von Makrophagen wird transkriptionell u.a. durch den Transkriptionsfaktor PPARγ (Peroxisomproliferator aktivierter Rezeptor γ) reguliert. Sein Zielgen FABP4 (Fettsäuren bindendes Protein 4) beschleunigt die Entwicklung von Arteriosklerose in Mausmodellen. Da die Expression von PPARγ und FABP4 in IL 4- (Interleukin-4) polarisierten Makrophagen induziert wird, sollte die Rolle von FABP4 in humanen, mit IL 4 polarisierten Makrophagen untersucht werden. Hierfür wurden primäre humane Monozyten in Anwesenheit von LPS/IFNγ (Lipopolysaccharid/Interferon γ) bzw. IL 4 zu Makrophagen differenziert. Es zeigte sich, dass in LPS/IFNγ stimulierten Makrophagen PPARγ und dessen Zielgene nicht exprimiert wurden. Dagegen waren sie bei unstimulierten Makrophagen bei IL 4 stimulierten Makrophagen deutlich erhöht. Dies spiegelte sich auch in einer erhöhten Aufnahme von Triglyceriden aus VLDL-Partikeln (Lipoproteinpartikel sehr niedriger Dichte) wider. IL 4 induzierte also einen Fettsäuren akkumulierenden Phänotyp. Durch einen PPAR-Luciferase-Reporter-Test wurde untersucht, ob FABP4 für die Aktivierung von PPARγ nötig war. Dies konnte bestätigt werden, da PPARγ durch seinen Liganden Linolsäure nur in Anwesenheit von FABP4 aktiviert werden konnte. Diese Aktivierung konnte zusätzlich durch den FABP4-Inhibitor HTS01037 verhindert werden. Nun sollte der Einfluss von FABP4 auf die PPARγ-abhängige Genexpression untersucht werden. Hierfür wurde FABP4 während der Differenzierung mit den beiden Inhibitoren HTS01037 oder BMS309403 in IL 4 stimulierten Makrophagen inhibiert. Durch die Inhibition von FABP4 sank die Expression von FABP4 und LPL (Lipoproteinlipase), während die von PPARγ unverändert blieb. Die LPL spielt eine entscheidende Rolle in der Aufnahme von Lipiden aus VLDL-Partikeln und trägt somit zur TG-reichen Schaumzellbildung bei. Die verminderte Expression von LPL spiegelte sich in einer verminderten Lipidaufnahme aus VLDL-Partikeln wider. Gleichzeitig wurde durch die FABP4-Inhibition die Entzündungsantwort der Makrophagen auf VLDL-Partikel abgeschwächt. IL 4 induziert also LPL, indem es PPARγ aktiviert. FABP4 unterstützt hierbei die Aktivierung von PPARγ. Durch die Inhibition kann die LPL-Expression vermindert werden, was die TG-reiche Schaumzellbildung und die Entzündungsreaktion in einem VLDL-reichen Umfeld vermindert und eine neue Therapiemöglichkeit von Arteriosklerose eröffnet. Im Fettgewebe kommt bei starkem Übergewicht, bedingt durch die erhöhte Konzentration an freien Fettsäuren und Hypoxie, zu einer leichten Entzündungsreaktion. Diese Entzündungsreaktion wurde durch eine Stimulation mit Palmitat unter Hypoxie (1 % O2) nachgebildet. Überstände von Makrophagen nach dieser Stimulation (MCM) wurden auf primäre humane Adipozyten übertragen. Diese Überstände konnten zwar keine Insulinresistenz in Adipozyten auslösen, induzierten jedoch eine Entzündungsreaktion. Diese zeigte sich in einer erhöhten Expression der proentzündlichen Zytokine CCL2 (CC-Chemokin-Ligand-2) und IL 6. Gleichzeitig wurde die Expression des antientzündlichen Zytokins Adiponectin vermindert. Der Transfer von MCM ist also ein Modell für die Entstehung der Insulinresistenz in einem frühen Stadium. Beim Versuch, die entzündungsfördernde Fähigkeit des MCMs zu verhindern, wurde AMPK mit verschiedenen Aktivatoren stimuliert. Es zeigte sich, dass der AMPK-Aktivator AICAR (5-Aminoimidazol-4-carboxamidribonukleotid) die Entzündungsantwort und den ER-Stress von mit Hypoxie und Palmitat stimulierten Makrophagen deutlich reduzierte. Der starke Effekt auf den ER-Stress konnte auch mit anderen ER-Stress-Auslösern wie Thapsigargin oder Tunicamycin nachvollzogen werden. Da AICAR ein AMPK-Aktivator ist, wurden typische Effekte der AMPK-Aktvierung wie reduzierte Proteinexpression, verstärkte Sirtuin-1-Aktivierung und Steigerung der Fettsäurenoxidation mittels Inhibitoren verhindert. Dies hatte keinen Einfluss auf die Wirkung von AICAR. Ebenso wurde untersucht, ob AICAR in die Zelle aufgenommen werden musste und ob es zu seiner phosphorylierten Form ZMP umgewandelt werden musste. Durch den Inhibitor ABT 702 kann die Adenosinkinase inhibiert werden, welche die Phosphorylierung katalysiert. Es zeigte sich, dass die Phosphorylierung von AICAR zu ZMP nicht erforderlich war, damit AICAR die ER-Stress-Antwort hemmen konnte. AICAR und nicht ZMP wirkte gegen den ER-Stress. Da durch das fehlende ZMP die AMPK nicht aktiviert wurde, war das ein weiteres Zeichen, dass AICAR AMPK-unabhängig wirkte. Dies konnte durch einen AMPK-Knockdown bestätigt werden. Durch einen Knockdown verschiedener Adenosintransporter konnte gezeigt werden, dass SLC28A3 (Soluttransporterfamlie 28 Typ A3) verantwortlich für die Aufnahme von AICAR in primäre humane Makrophagen war. Es konnte demnach gezeigt werden, dass AICAR den ER-Stress in primären humanen Makrophagen in einem von AMPK unabhängigen Mechanismus vermindert. Dafür wird es mittels SLC28A3 in die Zelle aufgenommen und wirkt als AICAR und nicht als ZMP. Diese Erkenntnisse stellen eine interessante, neue therapeutische Möglichkeit im Feld von Arteriosklerose und Diabetes dar.
Disturbances in lipid metabolism are responsible for many chronic disorders, such as type 2 diabetes and atherosclerosis. Regulation of lipid metabolism occurs by activated transcription factors peroxisome proliferator-activated receptor δ (PPARδ) and liver X receptor α (LXRα) mediating transcription of different target genes involved in regulation of fatty acid uptake and oxidation or cellular cholesterol homeostasis. This is especially relevant for the macrophages, since pathways regulated by PPARδ and LXRα affect foam cell formation, a process driving the progression of atherosclerotic lesion. AMP-activated protein kinase (AMPK) plays a central role in energy homeostasis in every type of eukaryotic cell, but its role in human macrophages, particularly with regard to lipid metabolism, is not precisely defined yet. Thus, I investigated the impact of AMPK activity on PPARδ and LXRα and the expression of their target genes involved in fatty acid oxidation (FAO) and cholesterol metabolism.
As PPARδ has been described as a potential target for prevention and treatment of several disorders and AMPK as interesting drug target for diabetes and metabolic syndrome, the aim of the first part of my studies was to investigate their interaction in primary human macrophages. Completing the first challenge successfully, I was able to establish a lentiviral transduction system for constitutively active AMPK (consisting of a truncated catalytic AMPKα1 subunit bearing an activating T198D mutation) in primary human macrophages.
Using genome-wide microarray analysis of gene expression, I demonstrate FAO as the strongest affected pathway during combined AMPKα1 overexpression and PPARδ activation.
The most influenced genes were validated by quantitative PCR as well as by Western analysis. I found that AMPK increases the expression of FAO-associated genes targeted by PPARδ. Corroborating the results obtained using AMPKα1 overexpression, PPARδ target gene expression was increased not only by PPARδ agonist GW501516, but also by pharmacological allosteric AMPK activator A-769662. Additional enhancement of target gene mRNA expression was achieved upon co-activation of PPARδ and AMPK. Silencing PPARδ expression increased basal expression of target genes, confirming the repressive nature of ligand-free PPARδ, abolishing the increased target gene expression upon AMPK or PPARδ activation. Measurements of triglyceride contents of human macrophages incubated with VLDL following PPARδ activation demonstrated a reduction of intracellular triglyceride accumulation in cells, which may reflect the enhancement of fat catabolism.
In the second part of my studies, I concentrated on the regulation of cholesterol transporter ATP-binding cassette transporter A1 (ABCA1) expression by AMPK. ABCA1 facilitates
cholesterol efflux from macrophages thus, preventing atherosclerosis progression. For the first time, AMPK implication in the regulation of the ABCA1 pathway could be presented. Both AMPK overexpression and activation lead to significantly increased ABCA1 expression, whereas AMPKα1 knock-down strongly reduced this effect. Besides, I was able to prove an enhanced activity of ABCA1 during AMPK activation in human THP-1 macrophages by measuring cholesterol efflux into apolipoprotein AI-containing medium.
Previous findings showed regulation of ABCA1 by LXRα. I confirmed these results by silencing experiments indicating an essential role of LXRα in ABCA1 regulation pathway.
Here, ABCA1 mRNA as well as protein expression were positively mediated by LXRα. LXRα activation elevated ABCA1 levels, whereas its silencing down-regulated this effect.
Interestingly, ABCA1 was found to be regulated only by LXRα and not through LXRα. At the same time, knock-down of PPARδ, -γ or -δ, which may be also involved in the regulation of LXR/ABCA1 axis, did not influence the activation of ABCA1 expression by an AMPK activator. To confirm that LXRE on Abca1 promoter is essential for ABCA1 regulation, I performed luciferase reporter assay using constructs based on Abca1 promoter with or without LXRE mutation. Mutation of LXRE abolished reporter activity, whereas AMPK activation increased luciferase activity of wild-type LXRE construct. Furthermore, I demonstrate AMPK-dependent LXRα binding to the LXRE site of Abca1 promoter using the method of chromatin immunoprecipitation. AMPK activation significantly increased, whereas silencing of AMPK significantly attenuated LXRα binding, indicating AMPK as one of the most important regulators of ABCA1 expression.
In summary, I provided an evidence for AMPK involvement into lipid and cholesterol metabolism in human macrophages showing the regulation of PPARδ and LXRα target genes. The understanding of AMPK and PPARδ interaction allows the development of new approaches for treatment of metabolic syndrome and related diseases. Increased FAO during the activation of both proteins may exhibit better therapeutic benefit. On the other hand, I have shown the impact of AMPK activation on ABCA1 via LXRα up-regulation leading to increased cholesterol efflux in human macrophages for the first time. These findings thus may impact future improving of anti-atherosclerosis therapies.
In dieser Arbeit werden Projekte beschrieben, in denen das Adsorptionsverhalten von Proteinen und Bakterien an verschiedene Materialoberflächen manipuliert wird.
Durch die Reaktion verschiedener oxidischer Oberflächen mit Glycidol konnten biorepulsive Polyglycerolschichten erzeugt werden. Für die Herstellung dieser Polyglycerolschichten wurden zwei unterschiedliche Verfahren entwickelt und untersucht. Die erste Methode beruht auf der Bildung einer aminoterminierten Monolage auf Silicium-Oberflächen, an der in einem zweiten Schritt die Polymerisation von Glycidol durchgeführt wird. Die Dicke der angebundenen Polyglycerolschicht ist abhängig von der Beschichtungsdauer, wobei die dicksten Schichten bis zu 98% der Bakterienadhäsion unterdrücken können. Das zweite Verfahren ist die direkte Anbindung von stabilen Polyglycerol-Beschichtungen an Silicium-, Aluminium- oder Stahl-Oberflächen. Je größer die abgeschiedene Polyglycerolmenge ist, desto höher ist die Biorepulsivität der Schicht, was durch Adsorptionstests mit Proteinen und ermittelt wurde.
Polyglycerolschichten eignen sich besonders gut für die nachträgliche Modifizierung. So konnten beispielsweise mittels Elektronenstrahlen laterale Strukturierungen der Polyglycerol-beschichteten Oberflächen erfolgreich durchgeführt werden. Sensorisch aktive Moleküle wie Ethylendiamintetraessigsäure oder Biotin konnten im Rahmen dieser Arbeit nachträglich an Polyglycerolschichten angebunden werden. Die Aktivität der Bindungsstellen nach der Anbindung an die Oberfläche konnte dabei durch spezifische Erkennungsereignisse nachgewiesen werden.
Im zweiten Teil dieser Arbeit wurden selbstanordnende Monoschichten mit Oligoethylenglycol (OEG)-Kopfgruppen und Thiolat-Ankergruppen verwendet, um lateral strukturierbare, biorepulsive Schichten auf Gold zu erzeugen. Es wurde untersucht, ob derartige OEG-Monolagen kontrolliert durch langwelliges UV-Licht (390 nm) abgebaut werden können, um proteinbindende und proteinrepulsive Bereiche auf einer Substrat-Oberfläche zu generieren. Die Bestrahlung mit UV-Licht bewirkte die Oxidation und Abspaltung der Ethylenglycol-Einheiten, wodurch die unspezifische Adsorption von Proteinen erfolgen kann. Zusätzlich konnten Photooxidations-Reaktionen an der Thiolat-Ankergruppe nachgewiesen werden, welche die Ablösung des SAM-Bausteins zur Folge haben.
Für den Einsatz von Lithographie-Techniken in mikrofluidischen Anlagen wurde das Abbauverhalten der biorepulsiven Monolage bei der Bestrahlung unter Wasser untersucht. In Abwesenheit von molekularem Sauerstoff kommt es hier lediglich zur Spaltung der Etherbindung zwischen den Ethylenglycol-Einheiten. Die Beobachtung, dass die An- bzw. Abwesenheit von molekularem Sauerstoff zu zwei unterschiedlichen Abbaumechanismen führt, kann für die Feinabstimmung der Oberflächenbeschaffenheit und somit der Proteinanlagerung genutzt werden.
Biorepulsive OEG-Monolagen können auch dazu verwendet werden, um gezielt bestimmte Biomoleküle anzulagern. Dazu können die Monolagen mit Erkennungsstellen ausgestattet werden, welche die spezifische Anbindung einer Biomolekül-Spezies ermöglichen. Gerade bei der Detektion von großen Biomolekülen oder Mikroorganismen spielt jedoch nicht nur die chemische Zusammensetzung, sondern auch die Ausrichtung der Bindungsstelle eine entscheidende Rolle. Für die Untersuchung des Orientierungseinflusses wurden Moleküle verwendet, die neben einer Mannose-Einheit als Bindungsstelle für Bakterien auch eine Azobenzol-Gruppe, welche die strahlungsinduzierte reversible Schaltung der Konformation ermöglicht, tragen. Bakterien-Adhäsionstests zeigten, dass sich die Orientierung der Mannose-Einheit auf die Anbindung der Bakterien auswirkt.
Im Rahmen dieser Arbeit wurden neuartige Methoden zur Herstellung, Charakterisierung und Strukturierung biorepulsiver und biosensorischer Schichten entwickelt. Die dadurch gewonnenen Erkenntnisse sind von bedeutender wissenschaftlicher Relevanz und ermöglichen die potentielle industrielle Anwendung der entwickelten Methoden im Kontext der Material- und Biotechnologie sowie der Nanofabrikation.
Since Inhibitor of Apoptosis (IAP) proteins are frequently dysregulated in different cancer entities and contribute to apoptosis resistance, pharmacological IAP antagonists are considered to be promising agents for the future development of cancer treatment strategies. IAP antagonists are small-molecule drugs that have been designed to mimic the interaction site of IAP proteins with their endogenous inhibitor Second mitochondrial activator of caspases (SMAC). Thus, they are frequently referred to as SMAC mimetics. Treatment with SMAC mimetics engages an apoptotic program in cancers by affecting different components of the apoptotic machinery. Besides disinhibition of caspases, SMAC mimetics trigger non-canonical nuclear factor-κB (NF-κB) signaling, which induces upregulation of tumor necrosis factor (TNF) α and other NF-κB target genes. In particular, TNFα production has been closely linked to the induction of SMAC mimetic-mediated cell death. The TNFα-dependent para/autocrine loop facilitates the formation of a cytosolic complex consisting of caspase-8, Fas-associated death domain (FADD) and Receptor-interacting protein (RIP) 1, which serves as caspase-8 activation platform and ultimately triggers induction of apoptosis. In the present study, we use the small-molecule bivalent SMAC mimetic BV6 to analyze SMAC-stimulated NF-κB signaling in cancer cell lines of different entities. Interestingly, we identify two novel NF-κB-regulated factors that are both required for SMAC mimetic-induced apoptosis in a context-dependent manner. First, we show that NF-κB-dependent upregulation of death receptor 5 (DR5) can serve as an alternative mechanism of BV6-mediated cell death. We demonstrate that BV6 treatment induces NF-κB-dependent but largely TNFα -independent apoptosis in A172 glioblastoma cells. By using an unbiased whole genome expression analysis approach, we identify DR5 as a critical NF-κB target gene, which substitutes TNFα and is indispensable for BV6-initated cell death in A172 cells. Second, we demonstrate that Interferon regulatory factor (IRF) 1 is required for BV6-induced TNFα production and apoptosis. Our study provides evidence that IRF1 closely cooperates with the NF-κB network in BV6-mediated cell death and additionally alters expression of selective SMAC mimetic-induced target genes. Furthermore, we show that BV6 treatment triggers secretion of a set of proinflammatory cytokines and increases attraction of monocytes to BV6-treated tumor cells in an IRF1-dependent manner. In summary, our work supports the notion that NF-κB-regulated factors are critically required for SMAC mimetic-initiated apoptosis. We show that IRF1 is indispensable for TNFα production and cell death in BV6-sensitive cell lines and that also DR5 can serve as a proapoptotic NF-κB-controlled factor in BV6-induced apoptosis besides TNFα. Furthermore, this study contributes to an improved understanding on non-apoptotic functions of SMAC mimetics, as IRF1 additionally influences expression levels of proinflammatory cytokines and attraction of immune cells. Thus, our work provides novel insights into the regulation of SMAC mimetic-induced signaling events, which is crucial for the translation of SMAC mimetics for use in clinical application.
In mitochondria, biogenesis of oxidase is a crucial process involving the participation of an array of assembly factors. Studying the process of biogenesis in eukaryotes is highly complicated due to the presence and partaking of two genetic systems. Employing a bacterial model such as Paracoccus denitrificans that utilizes only one genetic system enables easy studying of the assembly process. The aa3 cytochrome c oxidase of P. denitrificans shows high structural and functional homology to its mitochondrial counterpart despite its simple subunit composition. The assembly of the core subunits I and II that house the active redox centers (heme a, and heme a3.CuB centre in subunit I; and the binuclear CuA centre in subunit II) along with the chaperons responsibly for their incorporation form the crux of this work. This work concentrates particularly on CtaG, a chaperone previously speculated to be involved in the delivery of copper to the CuB center in subunit I. As the full length structure of CtaG or its structural homologues have not been solved, attempts were made to obtain high-diffracting crystals of CtaG by heterologously expressing it in E. coli. Growth media, expression strains and induction parameters were some of the conditions screened in order to obtain optimal yield. Additives, pH and detergent were screened to yield a homogeneous preparation of CtaG. Crystallization trials were conducted by employing the sitting drop, vapour diffusion, method and later the bicelles were employed. Preliminary crystals obtained were further optimized employing seeding, detergent and additives, to improve diffraction. The diffraction improved from 30 Å to 15 Å. BN PAGE (Blue Native Polyacrylamide Gel Electrophoresis) analysis and cross-linking studies were undertaken to decipher the oligomeric condition of CtaG. Both the methods indicate that the protein is a dimer under native conditions. To study the importance of CtaG in the process of oxidase assembly, two deletion mutants were obtained from the lab; one with only ctaG deleted and the other with ctaG and most of the upstream ORF. The effect of the deletion was assayed on the assembly and activity of oxidase. The deletion mutants showed residual activity of approx. 20 %, while displaying a very low heme signal (both in membranes and in purified COX). In order to exclude polar effects arising due to gene manipulation, complementation strains were prepared, reintroducing ctaG alone into both the deletion strains. Complementation strains, where only ctaG was deleted and re-introduced assayed for COX activity showed a restoration in activity to approx. 70 %. Further, calculating the heme:protein ratio, the deletion strains displayed a value of 7 nmol/mg of oxidase which was increased to wild type levels of 16 nmol/mg in the complementation strains. To further confirm the absence of the copper in subunit I, total reflection X-ray fluorescence spectroscopy analysis was carried out, which showed a decrease in the copper content in the deletion strain, restored on complementation. The strain lacking in the ORF and ctaG when complemented with ctaG alone illustrated no increase in activity or heme signal in comparison to that of the deletion strain. These point at a possible role for ORF in the assembly of COX, which is still absent in the complementation strains. To further characterize the ORF, a series of bioinformatical analysis was carried out, the results from which were insufficient to characterize the ORF conclusively. In order to enlist the proteins involved in the biosynthesis of COX, two independent approaches were employed. Two-dimensional gel examinations of solubilised membranes from untreated and cross-linked cells were analyzed by Western blotting. The CtaG-COX interaction was observed in untreated membranes, which was additionally strengthened by cross-linking. To further confirm this association, pull-down assays were done employing protein A coated magnetic beads coated with different antibodies and incubated with solubilised membranes derived from untreated or cross-linked cells. The elutions were assayed by Western blotting and confirmed for the CtaG-COX interaction. These fractions were further analysed by mass spectrometry to identify other chaperons involved in biogenesis of oxidase. Along with CtaG, I also noticed Sco, Surf1c and other factors involved in the recruitment and transport of heme (CtaB, CtaA, and Ccm proteins). Interestingly, protein components of both ribosomal subunits and protein translocation factors were observed, which indicated a co-translational approach for co-factor insertion into COX.
Im Rahmen der vorliegenden Arbeit wurde einerseits der Einsatz lichtaktivierbarer Oligonukleotide zur Kontrolle der Leitfähigkeit entlang von DNA untersucht sowie neue photoaktivierbare Verbindungen für die Peptidchemie und für eine neu entwickelte Variante des SELEX (Systematic Evolution of Ligands by EXponetial enrichment) Verfahrens synthetisiert.
DNA vermittelte Ladungsübertragung verläuft entlang des gestapelten π-Systems der heteroaromatischen Nukleobasen. Die Leitfähigkeit von Oligonukleotiden reagiert daher empfindlich auf Störungen in der Watson-Crick-Basenpaarung. Die in der Arbeitsgruppe Heckel etablierte Technik, Nukleobasen an für die Basenpaarung relevanten Positionen mit photolabilen Schutzgruppen zu modifizieren, sollte daher mit Systemen der Ladungsübertragung in DNA kombiniert werden. Im Verlauf dieses Projekts wurden zwei literaturbekannte Varianten, in denen Ladungstransport über einen lichtinduzierten Redoxprozess zwischen Metallkomplexen ablaufen und über eine dabei unterdrückte Fluoreszenz optisch verfolgt werden sollte, als ungeeignete Systeme identifiziert. Durch den Wechsel zu elektrodengestützter Leitfähigkeitsmessung konnte der prinzipielle Effekt von Leitfähigkeit in perfekt gepaarter DNA und deutlich reduziertem Stromfluss in Oligonukleotiden mit Fehlpaarungen gezeigt werden. Beim Einsatz photolabil geschützter Oligonukleotide konnte jedoch auch in diesem System noch nicht der gewünschte Effekt gefunden werden.
Im zweiten Projekt dieser Arbeit wurden neue photolabile Verbindungen hergestellt, die Peptide nach ihrem Einbau in das Peptidrückgrat durch Zwei-Photonen-Anregung mit IR-Licht spalten sollen. Drei entsprechende Nitrodibenzofuran-Verbindungen und ein Cumarin-Baustein konnten erfolgreich synthetisiert werden. Die neuen Moleküle zeigten im Rahmen der Peptid-Festphasensynthese Stabilitätsprobleme. Diese Schwierigkeiten konnten durch Peptid-Kopplungen in Lösung umgangen werden. Mit Hilfe eines der hergestellten Bausteine wurden zwei Tripeptide hergestellt, die jeweils mit dem Farbstoff ATTO565 markiert und hinsichtlich ihrer photochemischen Eigenschaften charakterisiert wurden. Der neue Baustein zeigte neben den Eigenschaften als photospaltbare Gruppe, dass er gleichzeitig ein Quencher für den Farbstoff ATTO565 darstellt. Nach Belichtung stieg die Fluoreszenz um den Faktor 81 an. Die Aktivierung gelang wie erwartet mit Ein- und Zwei-Photonen-Anregung. In Kollaboration mit der Arbeitsgruppe von Prof. Heilemann konnten Antiköper mit einem der Tripeptide modifiziert werden und die Kompatibilität der Verbindung mit hochaufgelöster Einzelmolekül-Fluoreszenzmikroskopie demonstriert werden.
Im letzten in dieser Arbeit thematisierten Projekt wurden neue lichtspaltbare Verbindungen für eine Variante des SELEX-Prozesses hergestellt. Diese Verbindungen erlauben die temporäre Einführung einer Indol Modifikation an Alkin-modifizierte Oligonukleotide über die sogenannte Click-Chemie. Neue chemische Modifikationen wie die hier verwendeten Indole erhöhen die chemische Vielfalt der Oligonukleotide. Eine größere Vielfalt führt zu neuen potentiellen Wechselwirkungen gegenüber Verbindungen, gegen die mit Hilfe herkömmlicher SELEX-Verfahren keine Aptamere erzeugt werden konnten. Da die chemische Modifikation über eine photolabile Gruppe an die Oligonukleotide gebunden wird, kann sie photochemisch von der DNA gespalten werden, wodurch eine Interferenz der Modifikation mit den enzymatisch katalysierten Schritten innerhalb der SELEX ausgeschlossen werden kann.
Necroptosis is a programmed cell death pathway that is implicated in a variety of human diseases. In recent years, increasing knowledge has been gained on the necroptotic signaling cascade. Nevertheless, the role of reactive oxygen species (ROS) in necroptosis is still ambiguous. In this study, we reveal that ROS critically regulate BV6/TNFα-induced necroptotic signaling in FADD-deficient Jurkat cells and in zVAD-treated MV4-11 cells. We show that several ROS scavengers such as butylated hydroxyanisole (BHA), N-acetylcysteine (NAC), α-tocopherol (αToc) and ethyl pyruvate (EP) significantly reduce ROS production and BV6/TNFα–induced cell death. Importantly, ROS are produced prior to cell death induction and promote the assembly of the Receptor-interacting protein kinase (RIP)1/RIP3 necrosome complex via a potential positive feedback loop since on the one hand radical scavengers diminish RIP1/RIP3 necrosome formation and since on the other hand RIP1 or RIP3 silencing attenuates ROS production. Furthermore, the deubiquitinase CYLD contributes to BV6/TNFα-induced ROS generation, necrosome assembly and cell death since CYLD knockdown attenuates all these events. Of note, knockdown of the downstream effector protein mixed lineage kinase domain like (MLKL) only partly reduces BV6/TNFα-triggered ROS production and cell death and does not affect necrosome formation. Contrary to expectations, the MLKL inhibitor Necrosulfonamide (NSA) not only decreases BV6/TNFα-stimulated ROS production and cell death but also attenuates RIP1/RIP3 necrosome assembly pointing to additional and MLKL-independent anti-necroptotic effects of NSA. Interestingly, silencing of the potential necroptotic excecutors mitochondrial proteins phosphoglycerate mutase family member 5 (PGAM5) or Dynamin-related protein 1 (Drp1) does not affect BV6/TNFα-induced cell death. Consistently, mitochondrial perturbations are not implicated in BV6/TNFα-induced cell death since mitochondrial membrane potential and respiration remain stable along with to BV6/TNFα-triggered necroptosis induction. Interference with the mitochondrial potential by depolarizing agents such as FCCP reduces BV6/TNFα-induced necroptosis indicating that proper mitochondrial function or a well-defined redox status is required for necroptotic cell death execution. This study demonstrates that ROS are critically involved in BV6/TNFα-induced necroptosis and thus provides novel insights into the redox regulation of necroptotic signaling.
To overcome poor treatment response of pediatric high-risk acute lymphoblastic leukemia (ALL), novel treatment strategies are required to reactivate programmed cell death in this malignancy. Therefore, we take advantage of using small-molecule antagonists of Inhibitor of apoptosis (IAP) proteins, so called Smac mimetics such as BV6, which are described to overcome apoptosis resistance and thereby sensitize tumor cells for several apoptotic stimuli. To address the question whether redox alterations can sensitize leukemic cells for Smac mimetic-mediated cell death, we interfered with the cellular redox status in different ALL cell lines. Here, we show for the first time that redox alterations, mediated by the glutathione depleting agent Buthioninesulfoximine (BSO), prime ALL cells for BV6-induced apoptosis. Besides ALL cell lines, BV6/BSO cotreatment similarly synergizes in cell death induction in patient-derived primary leukemic samples. In contrast, the combination treatment does not exert any cytotoxicity against peripheral blood lymphocytes (PBLs) or mesenchymal stroma cells (MSCs) from healthy donors, suggesting some tumor selectivity of this treatment. We also identify the underlying molecular mechanism of the novel synergistic drug interaction of BSO and BV6. We demonstrate that both agents act in concert to increase reactive oxygen species (ROS) production, lipid peroxidation and finally apoptotic cell death. Enhanced ROS levels in the combination treatment account for cell death induction, since several ROS scavengers, like NAC, MnTBAP and Trolox attenuate BSO/BV6-induced apoptosis. BSO/BV6-induced ROS can be mainly classified as lipid peroxides, since the vitamin E derivate α-Tocopherol as well as Glutathione peroxidase 4 (GPX4), which both specifically reduce lipid-membrane peroxides, prevent lipid peroxidation, caspase activation and cell death induction. Vice versa, GPX4 knockdown and pharmacological inhibition of GPX4 by RSL3 or Erastin enhance BV6-induced cell death. Importantly, cell death induction critically depends on the formation of a complex consisting of RIP1/FADD/Caspase-8, since all complex components are required for ROS production, lipid peroxidation and cell death induction. Taken together, we demonstrate that BSO and BV6 cooperate to induce ROS production and lipid peroxidation which are eventually required for caspase activation and cell death execution. Collectively, findings of this study indicate that BV6-induced apoptosis is mediated via redox alterations offering promising new treatment strategy to overcome apoptosis resistance in ALL.
Hepatocellular carcinoma (HCC) is the fifth most common malignant tumor and third leading cause of cancer-related death worldwide. Most cases arise as a consequence of underlying liver disease, e.g. developed from chronic hepatitis B or C infectionsalcohol abuse or obesity, and are most often associated with liver cirrhosis. Hypoxiand the hypoxia inducible factors (HIF)-1α and -2α promote tumor progression of HCC, not only affecting tumor cell proliferation and invasion, but also angiogenesis and lymphangiogenesis and thus, increasing the risk of metastasis.
HCC is characterized as one of the most vascularized solid tumors. While HIF-1α and HIF-2α are frequently up-regulated in HCC only HIF-2α is correlated with high patientlethality. HIF-dependent regulation of HCC angiogenesis is controversially discussed.VEGFA, for example, as the most prominent factor inducing tumor angiogenesis represents not only a HIF-1 target, but also a HIF-2 target gene in HCC. This questions whether both isoforms have overlapping functions in regulating the angiogenic switch in HCC.
Besides angiogenesis also tumor-associated lymphangiogenesis significantly influences patient survival in HCC. Lymphatic spread is an important clinical determinant for the prognosis of HCC, but little is known how lymphangiogenesis is controlled in this context. To date, mainly HIF-1α was positively correlated with olymphatic invasion and metastasis in HCC, while a defined role of HIF-2α is missing. Thus, although HIF-1α and HIF-2α are structurally alike and regulate overlapping but not identical sets of target genes, they promote highly divergent outcomes in cancer progression and may even have counteracting roles. The aim of my work was to characterize the specific role of HIF-1α and HIF-2α in the angiogenic switch and lymphangiogenesis induction during HCC development.
Therefore, I created a stable knockdown of HIF-1α and HIF-2α in HepG2 cells and generated cocultures of HepG2 spheroids and embryonic bodies derived from embryonic mouse stem cells as an in vitro tumor model mimicking the cancer microenvironment to analyze which HIF isoform has key regulatory functions in HCC (lymph)angiogenesis. In cocultures with a HIF-2α knockdown angiogenesis was attenuated but lymphangiogenesis increased, while the knockdown of HIF-1α was without effect. Microarray analysis identified plasminogen activator inhibitor 1 (PAI-1)and insulin-like growth factor binding protein 1 (IGFBP1) as HIF-2 target genes.However, prominent angiogenic and lymphangiogenic factors such as VEGFs, PDGFB, ANG and their receptors were not regulated in a HIF-dependent manner. As PAI-1 was linked to angiogenesis in literature and IGF-signaling, which is negatively regulated by IGFBP-1, was correlated with lymphangiogenesis, I decided to investigate their HIF-2α-dependent influence on HCC (lymph)angiogenesis. The knockdown of PAI-1 in HepG2 cells also lowered angiogenesis in PAI-1k/d cocultures similar to the HIF-2α k/d phenotype. PAI-1 as the potent inhibitor of tPA and uPA, both inducing the conversion of plasminogen to plasmin, also inhibits plasmin directly. Therefore, I assumed an increase of plasmin in HIF-2α k/d and PAI-1 k/d cocultures as a result of the reduced PAI-1 levels. Blocking plasmin with aprotinin in HIF-2α k/d cocultures restored angioge nesis, suggesting that HIF-2α increases PAI-1 to lower concentrations of active plasmin, thereby supporting angiogenesis. In further experiments I could exclude PAI-1 to reduce angiogenesis by inducing plasmin-mediated apoptosis of differentiating stem cells in PAI-1 k/d and HIF-2α k/d cocultures, but demonstrated an increase of VEGFA165 degradation in these cocultures, suggesting plasmin-catalyzed proteolysis of VEGF as an additional layer of regulation required to explain the angiogenic phenotype. Besides the pivotal role of PAI-1 in angiogenesis I also investigated its potentialinfluence in lymphangiogenesis. Indeed, the knockdown of PAI-1 reduced lymphaticstructures and implied an important but opposing role in lymphangiogenesis comparedto induced lymphangiogenesis in HIF-2α k/d cocultures. However, blocking plasmin again with aprotinin in HIF-2α k/d cocultures restored lymphangiogenesis to the level of control virus, which indicates a divergent lymphangiogenic role of plasmin in PAI-1 k/d and HIF-2α k/d cocultures, possibly because of other essential pathways masking the lymphangiogenic effects of PAI-1 in HIF-2α k/d cocultures.
HIF-2α resulting in reduced IGFBP1 expression induced the differentiation of stem cells toward a lymphatic cell type and significantly enhanced the assembly of human dermal lymphatic endothelial cells into tubes. These data point the first time to an important impact of HIF-2 in the regulatin of lymphangiogenesis in vitro by inducing IGFBP1 and thus, scavenging IGF-1. Furthermore, matrigel plug assays to investigate the in vivorelevance of these observations confirmed HIF-2α as a crucial factor in the regulation of lymphangiogenesis in vivo
In conclusion, this work provides evidence that HIF-2α is a key regulator of angiogenesis and lymphangiogenesis in HCC by regulating PAI-1 and IGFBP1. HIF-2α positively influences the angiogenic switch via PAI-1 and negatively affects lymphangiogenesis via IGFBP1 expression. Targeting HIF-2α in HCC to reduce tumor angiogenesis should be approached carefully, as it might be overcome by induced lymphangiogenesis and metastasis.
The RAF family of kinases constitutes the members A, B and CRAF. They mediate RAS signaling by linking it to the MEK/ERK transduction module, which regulates cellular processes such as cell proliferation, migration, survival and cell death. As the RAS/RAF/MEK/ERK (MAPK) pathway is found to be activated in human cancers, the RAF kinases have been exploited as valuable therapeutic targets and RAF inhibitors show promising results in the clinic, esp. with tumors harboring an activating BRAFV600E mutation. However, RAF inhibitors paradoxically accelerate metastasis in RAS mutant and BRAF wildtype tumors. They also become ineffective over time in BRAFV600E tumors because of reactivation of downstream mitogen-activated protein kinase (MAPK) signaling by promoting RAF dimerization. Aims of the present work were 1) to investigate the role of ARAF kinase in the paradoxical activation of the enzymatic cascade by RAF inhibitors downstream of mutated RAS and 2) to study the consequences of the loss of ARAF function on signal transduction in vitro and in vivo (nude mice). We have engineered several cell lines that would allow the study of basal and RAF inhibitor induced effects on MAPK activation, tumor cell migration and invasion.
In summary, we were able to show that the RAF isoform ARAF has an obligatory role in promoting MAPK activity and tumor cell invasion in a cell type dependent manner. In these cell types, ARAF depletion prevented the activation of MAPK kinase 1 (MEK1) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and led to a significant decrease of protrusions growing out of tumor cell spheroids in a three-dimensional (3D) culture that were otherwise induced by BRAFV600E-specific or BRAF/CRAF inhibitors (GDC-0879 and sorafenib, respectively). RAF inhibitors stimulated homodimerization of ARAF and heteromerization of BRAF with CRAF and the scaffolding protein KSR1. However, induced oligomerization was not sufficient to activate MAPK signaling if ARAF was depleted. By employing full length recombinant kinases, we were able to show for the first time that the three RAF isoforms competed for the binding to MEK1. In cell culture models, the overexpression of dimer-deficient ARAF mutants impaired the interaction between ARAF and endogenous MEK1 and thus prevented the subsequent phosphorylation of MEK1 and ERK1/2. Our findings reveal a new role for ARAF in directly activating the MAPK cascade through homodimerization and thereby promoting tumor cell invasion, suggesting the conserved RAF-dimer interface as a target for RAS- and RAF mediated cancer therapy.
Collectively, we provide evidence for the dual role ARAF plays in controlling MAPK signaling and cancer as loss of ARAF promoted strong lung metastasis formation in nude mice. Preliminary data describing the underlying mechanisms behind ARAF-regulated metastases have been presented and discussed.
Evaluierung der zellfreien Produktion sekundär aktiver Transporter für die Proteinkristallisation
(2013)
The four subunit (SU) aa3 cytochrome c oxidase (CcO) from Paracoccus denitrificans is one of the terminal enzymes of the respiratory chain. It uses electrons from cytochrome c to reduce molecular oxygen to water. Its binuclear active center, residing in SU I, contains hemeÊa3 and CuB, the latter being liganded by three histidine residues. Apart from its oxygen reductase activity, the protein possesses a peroxidase and a catalase activity.
To compare variants and the wild type (WT) protein in a more stringent way, a recombinant (rec.) WT CcO was constructed, carrying the gene for SUÊI on a low copy number plasmid. This rec. WT showed, as expected, no difference in oxygen reductase activity compared to the American Type Culture Collection (ATCC) WT CcO but surprisingly its catalase activity was increased by a factor of 20. The potential overproduction of SUÊI due to plasmid coding and the resulting deficiency in metal inserting chaperones might impair the correct insertion of hemeÊa3 and CuB because of a deficiency in metal inserting chaperones. This in turn might lead to differences in side chain orientation and to changes in the water network. However, slight changes might cause an increased accessibility of the active center for hydrogen peroxide, resulting in an increased catalase activity. The availability of chaperones and therefore the proposed structural reasons for the difference was improved by cloning the genes for the two metal inserting chaperones CtaG and Surf1c on the same plasmid together with SUÊI. This new rec. WT CcO showed in fact a reduced catalase activity. Another WT with a deletion in the chromosomal second, non expressing gene of SU I was analysed to prove plasmid coding as the reason for the difference of the ATCC WT and the rec. WT. This strain showed an increased kcat of the catalase activity as well, additionally pointing to a regulatory effect of the non expressed gene for SU I in the chromosome. To fathom the structural difference of the increased catalase activity, differential scanning calorimetry was used, but no significant difference in thermal stability between the ATCC WT CcO and the rec. WT CcO was detected. However, upon aging, the thermal stability of the rec. WT CcO declined faster than that of the ATCC WT CcO pointing to a decreased structural stability of the rec. WT CcO.
To characterize the catalase reaction, several known inhibitors were used to probe the contribution of the different metal cofactors in the catalase reaction. In addition variants in aromatic amino acids near the active center were constructed to conclude on a possible reaction mechanism of the catalase activity of CcO. These variants in combination with the wild type forms were analysed for radical signals by EPR-spectroscopy. A radical relevant for the catalase reaction of CcO was found in the F-intermediate of all variants and all wild type forms. This narrow 12 G radical signal was assigned to a porphyrine radical probably involved in the catalase reaction of CcO. Moreover, gas chromatography-mass spectrometry measurements were used to analyse isotopically labelled oxygen produced in the catalase reaction.
As a result of these experiments, a reaction cycle of the catalase activity of CcO is postulated and the structural difference between the ATCC and rec. WT CcO is outlined. The catalase activity appears to be a true catalase activity and not a "pseudocatalase" activity.
With only a 2.6 Å resolution laboratory powder diffraction pattern of the θ phase of Pigment Yellow 181 (P.Y. 181) available, crystal-structure solution and Rietveld refinement proved challenging; especially when the crystal structure was shown to be a triclinic dimethylsulfoxide N-methyl-2-pyrrolidone (1:1:1) solvate. The crystal structure, which in principle has 28 possible degrees of freedom, was determined in three stages by a combination of simulated annealing, partial Rietveld refinement with dummy atoms replacing the solvent molecules and further simulated annealing. The θ phase not being of commercial interest, additional experiments were not economically feasible and additional dispersion-corrected density functional theory (DFT-D) calculations were employed to confirm the correctness of the crystal structure. After the correctness of the structure had been ascertained, the bond lengths and valence angles from the DFT-D minimized crystal structure were fed back into the Rietveld refinement as geometrical restraints (‘polymorph-dependent restraints’) to further improve the details of the crystal structure; the positions of the H atoms were also taken from the DFT-D calculations. The final crystal structure is a layered structure with an elaborate network of hydrogen bonds.
The knowledge of three-dimensional structures of biomolecules is fundamental for the understanding of their function. Nuclear magnetic resonance (NMR) spectroscopy represents besides X-ray crystallography one of the two most widely used techniques to study macromolecules at atomic resolution. Its application has long been a laborious task that could take months and required the expertise of an experienced scientist, however, owing to the tremendous effort that has been put into the development of respective computer algorithms, structure determination by NMR spectroscopy of small- to medium sized proteins is nowadays routinely performed. CYANA is one widely used software package, which combines the majority of individual steps towards a three-dimensional structure. The most common application of the program, however, restricts to the combined automated NOE assignment and structure calculation based on NOESY peak lists and an existing chemical shift assignment. Completely automated structure determination starting from NMR spectra is to date technically possible with CYANA, however, not yet routinely applied. In order to achieve this long-term goal, the individual steps need to become more robust with regard to data imperfections such as peak overlap, spectral artifacts or a limited amount of NMR data. The work presented in this thesis should be placed within the context of increasing the reliability and improving the accuracy of structures determined by CYANA on the basis of solution- as well as solid-state NMR data.
The chapter “Systematic evaluation of combined automated NOE assignment and structure calculation with CYANA” comprises an extensive study on the robustness of the combined automated NOE assignment and structure calculation algorithm based on experimental solution NMR data sets that were modified in multiple ways to mimic different kinds of data imperfections. The results show that the algorithm is remarkably robust with regard to imperfections of the NOESY peak lists and the chemical shift tolerances but susceptible to lacking or erroneous resonance assignments, in particular for nuclei that are involved in many NOESY cross peaks.
In the chapter “Peakmatch – A simple and robust tool for peaklist matching” a method to achieve self-consistency of the chemical shift referencing among a set of peak lists is presented. The Peakmatch algorithm matches a set of peak lists to a specified reference peak list, neither of which have to be assigned, by optimizing an assignment-free match-score function. The algorithm has been extensively tested on the basis of experimental NMR data sets of five different proteins. The results show that peak lists from many different types of spectra can be matched reliably as long as they contain at least two corresponding dimensions.
NMR structures are represented by bundles of conformers whose spread indicates the precision of the atomic coordinates. However, there is as yet no reliable measure of structural accuracy, i.e. how close NMR conformers are to the “true” structure. Instead, the precision of structure bundles is widely (mis)interpreted as a measure of structural quality. Attempts to increase the precision thus often yield tight structure bundles where the precision overestimates the accuracy. To overcome this problem, the chapter “Increased reliability of NMR protein structures by consensus structure bundles” introduces a new protocol for NMR structure determination with the software package CYANA that produces bundles of conformers with a realistic precision that is throughout a large number of test data sets a much better estimate of the structural accuracy than the precision of conventional structure bundles.
Solid-state NMR is a powerful technique to study molecules which are not amenable to either solution NMR or X-ray crystallography. Despite the reporting of individual atomic resolution structures of membrane proteins and amyloid fibrils based on solid-state NMR data, the application is far from routine. One major obstacle that hinders structure determination by solid-state NMR is the overall lower quality of the solid-state NMR spectra. It is therefore necessary to increase the robustness of the computer algorithms in order to improve the results when using lower quality solid-state NMR spectra. The chapter “Structure calculations of the model protein GB1 from solid-state NMR data” presents structure calculations on the basis of a set of two-dimensional solid-state NMR experiments of the model protein GB1. The most important result obtained from these test calculations is that the limitation of structural accuracy can be attributed to inaccurate distance information resulting from the limited correlation between peak intensities and distance, which is especially severe in spin diffusion-based solid-state NMR experiments.
The chapter “Full relaxation matrix-based correction of relayed polarization transfer for solid-state NMR structure calculation” therefore introduces a method which corrects experimental peak intensities for spin diffusion in order to improve the distance information from solid-state NMR spectra. The results show that the structural accuracy can be significantly improved when using the corrected distance information, however, strongly dependent on the preliminary structural model that is required as input for the method.
Die Sulfonyl-Gruppe (-SO2-) ist ein weit verbreitetes Strukturmotiv in der organischen Chemie und Bestandteil vieler biologisch aktiver Moleküle, insbesondere Arzneistoffen. Zwei der am häufigsten auftretenden Gruppen sind Sulfone und Sulfonamide, die in über 100 zugelassenen Medikamenten und 10% der meistverkauften Medikamente sind. Insofern kommt der Entwicklung neuer Synthesemethoden eine große Bedeutung zu. Dabei stehen besonders einfache, wirtschaftliche und zeitsparende Vorgehensweisen im Vordergrund, die eine große Bandbreite an neuen Substanzen generieren können. Ein Ansatz hierfür sind Multikomponenten- oder Eintopfreaktionen.
Aufgrund der Wichtigkeit dieser zwei Strukturklassen, sollen im Rahmen der hier vorliegenden Doktorarbeit neue Syntheserouten für Sulfone und Sulfonamide entwickelt werden. Besonderes Augenmerk wird auf die die Einführung der SO2-Einheit während der Reaktionsführung gelegt. Im Vergleich zu bereits existierenden Verfahren ist dies ein enormer Fortschritt, da die Mehrheit der bekannten Routen auf Schwefel- oder Schwefeldioxid-haltige Startmaterialien zurückgreift.
In der vorliegenden Arbeit gelang es, einen synthetischen Zugang zu Arylsulfonen basierend auf von Natrium-, Lithium-, Magnesium- und Zinksulfinaten zu finden. Diese Reaktion besitzt eine sehr große Anwendungsbandbreite und setzt sowohl Aryl- als auch Alkylsulfinate effizient um. Außerdem weisen Reaktionen mit unsymmetrischen Diaryliodoniumsalzen hohe Chemoselektivitäten auf.
Auf der Grundlage auf der Reaktion zwischen Natriumsulfinaten und Iodoniumsalzen wurde eine simple Route zur Synthese von Diarylsulfonen abgeleitet, jedoch war hierbei die Sulfonylgruppe noch Bestandteil eines der Edukte. Um die SO2-Einheit während der Reaktion einführen zu können, wurde ein praktisches Eintopf-Protokoll entwickelt, welches die direkte Umsetzung von (hetero)aromatischen und alkylischen Halogeniden zu Arylsulfonen gestattet. Diese innovative Methode besteht aus folgenden vier Schritten: (1) Generierung des Organometallreagenzes via Halogen-Metall-Austausch, direkte Metallinsertion oder Deprotonierung; (2) Reaktion des Organometallreagenzes mit SO2 zum Sulfinat; (3) Entfernen des SO2-Überschusses und flüchtiger Komponenten und (4) Umsetzung des nicht aufgereinigten Sulfinates mit einem Iodoniumsalz.
Desweiteren wird in dieser Arbeit ein neuartiger Übergangsmetall-katalysierter Ansatz zur Darstellung von Diarylsulfonen ausgehend von Arylhalogeniden und Sulfinaten diskutiert. Erste Experimente deuten auf Nickel-Katalysatoren als gute Wahl für die Reaktion. Optimierungsreaktionen zeigten eine starke Abhängigkeit der Ausbeute in Hinsicht auf die Bisswinkel der an das zentrale Nickelatom koordinierten Liganden. Da die bis dato besten Ergebnisse mit dem Komplex [o-tol-Ni(PPh2Me)2Cl] erzielt wurden, wird der [o-tol-Ni(PMe3)2Cl]-Komplex momentan in unserem Labor weiteren Studien unterzogen. Bislang ist davon auszugehen, dass dieser Katalysator hervorragende Ergebnisse liefert und zu einer allgemein gültigen Methode führt.
In weiteren Kapiteln wird die Anwendbarkeit von SO2-Surrogaten, Metabisulfiten „S2O52-„ oder DABSO; untersucht; mit dem Ziel eine Eintopf- oder Multikomponentenreaktion zu entwickeln.
Zum einen wird die Entwicklung einer Ein-Topf-Reaktion von Alkylhalogeniden mit Metabisulfiten und Organozinkreagenzien zur Darstellung von Alkylarylsulfonen vorgestellt. Darüber hinaus wird eine Übergangsmetall-katalysierte Multikomponenten Reaktion zur Synthese von Sulfonsäureamiden vorgestellt. Eine Reaktion zwischen Aminen, Arylhalogeniden und DABSO als SO2-Quelle wurde in Form einer Palladium-katalysierten Aminosulfonylierung entwickelt.